Comments
With reference to the above, we would like to inform that the Board of Directors of the Company at their meeting held today, i.e. on Tuesday, August 14, 2018, had approved the following; 1.To Considered and Approved Standalone and Consolidated Un-Audited Financial Results for the Quarter Ended on June 30, 2018. 2.The Limited Review Report on Standalone and Consolidated Un-Audited Financial Results received from Statutory Auditors for the aforesaid Quarter. 3.The Financial Performance Highlights for the Quarter Ended on June 30, 2018.
Pdf Link: Lincoln Pharmaceuticals Ltd. - Results-Financial Result For June 30, 2018
Source : BSE - www.bseindia.com
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.